Semiconductor equipment suppliers compete on precision, process stability and reliable integration into demanding production environments. Their patent portfolios must remain relevant as customer requirements and competing machines evolve. This CEIPI lecture connects valuable technical functions, pending patent applications and practical protection with management concepts explored on the IPBA Plattform. Commercially useful protection requires both a relevant claim position and a realistic understanding of what can be observed, proven and kept confidential.

When equipment moves faster than the portfolio

Consider a supplier whose earlier applications describe positioning, alignment or process-control solutions. During examination, a competitor introduces equipment that delivers a similar customer benefit through a different configuration. The management question is whether the existing portfolio can still protect an economically important position. Counting applications or checking whether claims describe the supplier’s own machine does not answer it.

A concentrated competitor landscape can make focused monitoring manageable. The IPBA Plattform’s IP Business Intelligence entry explains how patent information and business context inform decisions. Yet a small number of rivals does not make their machines accessible. Equipment may be expensive, sales to competitors restricted and internal processes difficult to reconstruct. Product announcements and performance specifications provide useful signals, but they rarely establish every technical feature needed for a claim comparison.

The decisions behind competitor targeting

Competitor targeting connects those signals with the review of existing applications while prosecution remains open. A current competitor product may trigger the review; predicting its future development is not a prerequisite. The team identifies the commercially relevant function, checks filing dates and procedural status, and tests whether the original disclosure supports useful claim options.

For European applications, market relevance does not permit new matter. Article 123 EPC constrains amendments, while the EPO’s divisional framework requires a pending parent. Simply deleting an inconvenient feature is not enough: the resulting combination needs adequate original support and must meet the applicable patentability requirements. A new filing cannot retrospectively obtain the earlier application’s date for newly added subject matter.

Evidence therefore belongs in the review from the beginning. A visible arrangement, measured behaviour and hidden control logic present different proof problems. Similar output may result from different internal methods. Management needs an explicit account of the evidence available for each relevant feature, the remaining uncertainty and the cost of closing the gap. The dIPlex Deep Dive Complementary Patent Prosecution and Litigation on the IPBA Plattform develops this connection between claim development and later enforcement.

Three perspectives on competitive value

Three complementary perspectives help structure the decision. The IPBA Plattform’s dIPlex chapter Integration of IP into Common Management Concepts connects protection with value appropriation: how a company captures returns from innovation. Applied to equipment suppliers, the question is which protection choices preserve a valuable market position or support licensing and negotiation. Integration expertise, process knowledge and service capabilities also contribute to the customer benefit being protected.

The IP Management Letter IP in the Resource-Based View explains the VRIN criteria: valuable, rare, difficult to imitate and non-substitutable resources. For this case, learners should assess whether an advantage resides in a patentable technical function, accumulated calibration knowledge or confidential recipes. A patent count alone cannot establish these qualities. Publishing sensitive details without gaining useful protection may weaken the resource the company intended to preserve.

Our IP Management Letter David Teece’s Dynamic Capabilities adds the organisational capacity to sense change, seize opportunities and reconfigure resources. Applied here, competitor signals should trigger timely portfolio reviews, supported by decisions on evidence, prosecution and budget. Product, R&D and IP teams need a shared process for acting on those signals. This is an application of the framework to the case, rather than a claim that it prescribes a particular prosecution tactic.

Two industrial cases with different outcomes

Rudolph Technologies and Camtek show how wafer-inspection patents can affect specific equipment generations. In February 2016, Camtek reported a final ruling involving approximately US$14.6 million in damages including interest and a US injunction concerning Falcon systems. Camtek also stated that those systems had not been sold in the United States for several years. Timing therefore matters when assessing the commercial effect of exclusion.

A separate US$13 million settlement in July 2017 resolved later disputes and provided defined rights concerning existing and future products, including reciprocal rights relating to kerf inspection. These are distinct events, not interchangeable measures of one award. They illustrate the economic consequences of product-relevant patent positions, while leaving litigation costs and net returns outside the reported figures.

Nikon, ASML and ZEISS illustrate negotiated access at portfolio level. The parties signed their definitive settlement in February 2019. The published agreement provided for €150 million to Nikon and royalties of 0.8% in each direction on defined immersion-lithography system sales. Reciprocal licences supported an agreed operating framework. These historical terms are not a general royalty benchmark.

Together, the cases distinguish direct exclusion from negotiated access. Neither public record establishes that the outcomes resulted from deliberate claim tailoring during prosecution. Their teaching value lies in connecting technical relevance, timing and business objectives, while preserving that evidentiary limit.

Turning the lecture into a portfolio review

The lecture translates these perspectives into a practical review: choose a valuable function, map the relevant family, assess supported claim options and identify feasible evidence routes. Two dIPlex resources on the IPBA Plattform help organise this work. Patent Portfolio Management and Strategy connects portfolio decisions with business priorities. Patent Portfolio Analysis supports assessment of strategic fit and the allocation of resources across families.

The protection mix also needs implementation. Restricted access to recipes and code, documented confidentiality and separation of sensitive modules can complement patents. Complexity may hinder reverse engineering, but it should not compromise reliability, safety or serviceability. The IPBA Plattform’s discussion of documented trade-secret protection explains why practical measures and their records matter. Each review should end with an owner, budget and decision date before relevant procedural opportunities close.

Preparing a reasoned answer to the practical question

The accompanying practical question asks learners to bring these choices together in a semiconductor-equipment setting. A strong response should justify priorities, recognise evidence limitations and explain when patents, confidentiality and technical safeguards reinforce one another. The planned expert model solution will develop those choices into a reasoned response and an actionable review process. Use the lecture slides below to work through the framework and explore the linked readings before developing your own answer.